Oncolytics down on bigger-than-expected Q2 loss

Oncolytics Biotech

14/08/2023 15:52

** U.S.-listed shares of Canadian biotech company Oncolytics
Biotech  ONCY.O  fall 2% to $1.99 
    ** Co reports Q2 loss of 12 cents per share vs analysts'
average estimate of a loss of 11 cents/shr
    ** All of the 6 brokerages covering the stock rate it "buy"
or higher, their median PT is $5
    ** Including session moves, stock up 19.9% YTD

 (Reporting by Christy Santhosh in Bengaluru)
 ((Christy.Santhosh@thomsonreuters.com))